There are 859 resources available
510MO - Trastuzumab deruxtecan (T-DXd) in Asian patients (Pts) with human epidermal growth factor receptor 2 (HER2; ERBB2)-mutant (HER2m) metastatic non-small cell lung cancer (mNSCLC): Subgroup analysis of DESTINY–Lung02 (DL-02)
Presenter: Yasushi Goto
Session: Mini oral session 1: Thoracic cancer
Resources:
Abstract
Slides
Webcast
257O - Association of enzalutamide (ENZA) duration of treatment (DOT) and overall survival (OS) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Post hoc analysis from PREVAIL
Presenter: Edmund Chiong
Session: Proffered Paper session: Genitourinary tumours
Resources:
Abstract
Slides
Webcast
Invited Discussant 508MO, 509MO and 510MO
Presenter: Lizza Hendriks
Session: Mini oral session 1: Thoracic cancer
Resources:
Slides
Webcast
Invited Discussant 255O, 256O and 257O
Presenter: Deborah Mukherji
Session: Proffered Paper session: Genitourinary tumours
Resources:
Slides
Webcast
Genomic technologies for cancer risk prognostication and early detection
Presenter: Maximilian Diehn
Session: In collaboration with AACR: Early detection of cancer
Resources:
Slides
Webcast
Q&A and discussion
Presenter: All Speakers
Session: New treatment options for sarcomas
Resources:
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Proffered Paper session: Breast cancer
Resources:
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Proffered Paper session: Head and neck cancer
Resources:
Webcast
LBA5 - Capivasertib (C) + fulvestrant (F) for patients (pts) with aromatase inhibitor (AI)-resistant HR+/HER2– advanced breast cancer (ABC): Phase III CAPItello-291 trial Chinese cohort
Presenter: Xichun Hu
Session: Proffered Paper session: Breast cancer
Resources:
Abstract
Slides
Webcast
Q&A and discussion
Presenter: All Speakers
Session: In collaboration with AACR: Early detection of cancer
Resources:
Webcast